These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 17525051

  • 1. Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters.
    Aslam S, Darouiche RO.
    J Antimicrob Chemother; 2007 Jul; 60(1):148-51. PubMed ID: 17525051
    [Abstract] [Full Text] [Related]

  • 2. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [Abstract] [Full Text] [Related]

  • 3. In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistance.
    Munson EL, Heard SO, Doern GV.
    Chest; 2004 Nov; 126(5):1628-35. PubMed ID: 15539737
    [Abstract] [Full Text] [Related]

  • 4. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
    Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE.
    J Antimicrob Chemother; 2005 May; 55(5):792-5. PubMed ID: 15814598
    [Abstract] [Full Text] [Related]

  • 5. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE, Poppens PT.
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 9. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.
    Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I.
    J Antimicrob Chemother; 2007 Mar; 59(3):359-69. PubMed ID: 17255143
    [Abstract] [Full Text] [Related]

  • 10. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria.
    Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R.
    J Antimicrob Chemother; 2008 Oct; 62(4):746-50. PubMed ID: 18653489
    [Abstract] [Full Text] [Related]

  • 11. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
    Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R.
    Antimicrob Agents Chemother; 2007 May; 51(5):1656-60. PubMed ID: 17353249
    [Abstract] [Full Text] [Related]

  • 12. Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci.
    Tsao SM, Lin HC, Lee CM, Hsu GJ, Chen CM, Sun W, Liu YC, Jang TN, Cheng YJ, Lu PL, Chiang PC, Wang LS, Kung HC, Chuang YC, Shi ZY, Liu JW, Huang CH, Lu CT, Liao CH, Hsueh PR.
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S184-7. PubMed ID: 19013352
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Garrison MW, Nuemiller JJ.
    Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
    [Abstract] [Full Text] [Related]

  • 14. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
    Cirioni O, Giacometti A, Ghiselli R, Kamysz W, Orlando F, Mocchegiani F, Silvestri C, Licci A, Chiodi L, Lukasiak J, Saba V, Scalise G.
    Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
    [Abstract] [Full Text] [Related]

  • 15. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G, White R, Friedrich L.
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [Abstract] [Full Text] [Related]

  • 16. Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial.
    Rodloff AC, Leclercq R, Debbia EA, Cantón R, Oppenheim BA, Dowzicky MJ.
    Clin Microbiol Infect; 2008 Apr; 14(4):307-14. PubMed ID: 18261126
    [Abstract] [Full Text] [Related]

  • 17. Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial.
    Denys GA, Koch KM, Dowzicky MJ.
    Am J Infect Control; 2007 Oct; 35(8):521-6. PubMed ID: 17936143
    [Abstract] [Full Text] [Related]

  • 18. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z, Cao B, Liu YM, Gu L, Wang C.
    Chin Med J (Engl); 2009 Jun 05; 122(11):1283-8. PubMed ID: 19567138
    [Abstract] [Full Text] [Related]

  • 19. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R.
    Crit Care Med; 2006 Mar 05; 34(3):668-75. PubMed ID: 16505651
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
    Zhanel GG, DeCorby M, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, Mulvey MR, Hoban DJ, Canadian Antimicrobial Resistance Alliance.
    Diagn Microbiol Infect Dis; 2008 Sep 05; 62(1):67-80. PubMed ID: 18513913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.